SherrardD.J., HerczG., PeiY., MaloneyN.A., GreenwoodC., ManuelA.The spectrum of bone disease in end-stage renal failure: an evolving disorder.Kidney Int1993; 43: 436–42.
3.
CoburnJ.W.Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.Kidney Int1993; 43(Suppl 40): 92–100.
4.
TorresA., LorenzoV., HernandezD., RodriguezJ.C., ConcepciónM.T., RodriguezA.P.Bone disease in predialysis, hemodialysis and CAPD patients: evidence of a better response to PTH.Kidney Int1995; 47: 1434–42.
5.
YamamotoM., IgarashiT., MuramatsuE., FukagawaM., MotokuraT., OgataE.Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat.J Clin Invest1989; 83: 1053–6.
6.
Naveh-ManyT., SilverJ.Regulation of parathormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat.J Clin Invest1990; 86: 1313–19.
7.
RodriguezM., AlmadénY., HernandezA., TorresA.Effect of phosphate on the parathyroid gland: direct and indirect?Curr Opin Nephrol Hypertens1996; 5: 213–28.
8.
HernandezA., ConcepciónM., RodriguezM., SalidoE., TorresA.High phosphorus diet increases prepro PTH mRNA independent of calcium and calcitriol.Kidney Int1996; 50: 1872–8.
BrownE.Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other ions as extracellular (first) messengers.Physiol Rev1991; 71: 371–411.
11.
FermentO., GarnierP., TouitouY.Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man.J Endocrinol1987; 113: 117–22.
12.
CholstI., SteinbergS., TropperP., FoxM., SegreG., BileziianJ.The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.N Engl J Med1984; 310: 1221–5.
13.
GoughI.R., BaldersonG.A., LloydH.M., GalliganJ., WillgossD., FryarB.G.The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism.World J Surg1988; 12: 463–9.
14.
NavarroJ.F., MacíaM.L., GallegoE., MéndezM.L., ChahinJ., García-NietoV.Serummagnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease?Scand J Urol Nephrol1997; 31: 275–80.
15.
TakahashiS., OkadaK., YanaiM.Magnesium and parathyroid hormone changes to magnesium free dialysate in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1994; 14: 75–8.
16.
EjazA.A., McShaneA.P., GandhiV.C., LeeheyD.J., IngT.S.Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.Perit Dial Int1995; 15: 61–4.
17.
HutchinsonA.J., WereA.J., BoultonH.F., MawerE.B., LaingI., GokalR.Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: Improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations.Nephron1996; 72: 52–8.
18.
BlumenkrantzM.J., KoppleJ.D., MoranJ.K., CoburnJ.W.Metabolic balance studies and dietary protein requirements in patients undergoing continuous peritoneal dialysis.Kidney Int1982; 21: 849–61.
19.
DelmezJ.A., SlatopolskyE., MartinK.J., GearingB.N., HasterH.R.Mineral, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis.Kidney Int1982; 21: 862–7.
20.
BuckleR., CareA., CooperC., GitelmanH.The influence of plasma magnesium concentration on parathyroid hormone secretion.J Endocrinol1968; 42: 529–34.
21.
MassryS.G., CoburnJ.W., KleemanC.R.Evidence for supression of parathyroid gland activity by hypermagnesemia.J Clin Invest1970; 49: 1619–29.
22.
WallaceJ., ScarpaA.Regulation of parathyroid hormone secretion in vitro by divalent cations and cellular metabolism.J Biol Chem1982; 257: 10613–16.
23.
BrownE.Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other ions as extracellular (first) messengers.Physiol Rev1991; 71: 371–411.
24.
PletkaP., BernsteinD.S., HampersC.L., MerrillJ.P., SherwoodL.M.Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.Metabolism1974; 23: 619–30.
25.
PeiY., HerczG., GreenwoodC., SegreG., ManuelA., SaiphooC.Risk factors for renal osteodystrophy: a multivariant analysis.J Bone Miner Res1995; 10: 149–58.
26.
HerczG., PeiY., GreenwoodC., ManuelA., ShaipooC., GoodmanW.G.Aplastic osteodystrophy without aluminum: the role of suppressed parathyroid function.Kidney Int1993; 44: 860–6.
27.
FournierA., HardyP., HueP., SaidS., HamdiniN., EldinH.M.Adynamic bone disease in patients with uremia.Curr Opin Nephrol Hypertens1994; 3: 396–410.
28.
HutchinsonA.J., MooreP.R.Low turnover bone disease.Perit Dial Int1996; 16(Suppl 1): 295–9.
